
- /
- Supported exchanges
- / DU
- / GIS.DU
GILEAD SCIENCES - Dusseldorf Stock Exchang (GIS DU) stock market data APIs
GILEAD SCIENCES - Dusseldorf Stock Exchang Financial Data Overview
There is no Profile data available for GIS.DU.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get GILEAD SCIENCES - Dusseldorf Stock Exchang data using free add-ons & libraries
Get GILEAD SCIENCES - Dusseldorf Stock Exchang Fundamental Data
GILEAD SCIENCES - Dusseldorf Stock Exchang Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
Get GILEAD SCIENCES - Dusseldorf Stock Exchang Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
Get GILEAD SCIENCES - Dusseldorf Stock Exchang End-of-day data
EOD Historical Data package for
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
GILEAD SCIENCES - Dusseldorf Stock Exchang News

Biotech stocks: Who wins and who loses if RFK, Jr. goes
Investing.com -- RBC Capital said the potential departure of Health and Human Services Secretary Robert F. Kennedy Jr. could have wide-ranging implications for the biotech sector, with both winners an...


Here's How You Can Earn $100 In Passive Income By Investing In Gilead Sciences Stock
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Gilead Sciences Inc. (NASDAQ:GILD) is an American biopharmaceutical company that researches, devel...

Gilead Sciences (GILD) Exceeds Market Returns: Some Facts to Consider
Gilead Sciences (GILD) closed the most recent trading day at $117.86, moving +2.26% from the previous trading session. The stock outperformed the S&P 500, which registered a daily gain of 0.85%. Elsew...

Biotechs Could Benefit If RFK Jr. Leaves HHS
This article first appeared on GuruFocus. Biotech investors may have something to gain if Health and Human Services Secretary Robert F. Kennedy Jr. were to step aside. RBC Capital Markets analyst Bri...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.